NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018.

Published

Journal Article

The NCCN Guidelines for Thyroid Carcinoma provide recommendations for the management of different types of thyroid carcinoma, including papillary, follicular, Hürthle cell, medullary, and anaplastic carcinomas. These NCCN Guidelines Insights summarize the panel discussion behind recent updates to the guidelines, including the expanding role of molecular testing for differentiated thyroid carcinoma, implications of the new pathologic diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features, and the addition of a new targeted therapy option for BRAF V600E-mutated anaplastic thyroid carcinoma.

Full Text

Duke Authors

Cited Authors

  • Haddad, RI; Nasr, C; Bischoff, L; Busaidy, NL; Byrd, D; Callender, G; Dickson, P; Duh, Q-Y; Ehya, H; Goldner, W; Haymart, M; Hoh, C; Hunt, JP; Iagaru, A; Kandeel, F; Kopp, P; Lamonica, DM; McIver, B; Raeburn, CD; Ridge, JA; Ringel, MD; Scheri, RP; Shah, JP; Sippel, R; Smallridge, RC; Sturgeon, C; Wang, TN; Wirth, LJ; Wong, RJ; Johnson-Chilla, A; Hoffmann, KG; Gurski, LA

Published Date

  • December 2018

Published In

Volume / Issue

  • 16 / 12

Start / End Page

  • 1429 - 1440

PubMed ID

  • 30545990

Pubmed Central ID

  • 30545990

Electronic International Standard Serial Number (EISSN)

  • 1540-1413

Digital Object Identifier (DOI)

  • 10.6004/jnccn.2018.0089

Language

  • eng

Conference Location

  • United States